The effect of obesity on dexmedetomidine dosing in ICU patients - retrospective study

The effect of obesity on dexmedetomidine dosing in ICU patients - retrospective study - Obesity and dexmedetomidine dosing

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000012466

Enrollment

Registered

2013-12-03

Start date

2013-12-03

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

ASA Physical state 1 to 3, 18 - 80 year old patients who underwent elective surgery and received intravenous dexmedetomidine in the ICU

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: ASA PS 1 to 3

Exclusion criteria

Exclusion criteria: History of neuropsychiatric disorder Taking psychiatric drugs Consciousness disturbance Underwent brain surgery Brain injury Underwent hepatectomy

Design outcomes

Primary

Measure	Time frame
dexmedetomidine dosing	—

Countries

Japan

Contacts

Public ContactShinju Obara

Fukushima Medical University Anesthesiology

shinjn@fmu.ac.jp0245471342

Outcome results